Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seunghwan Shin

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Joint Bone Spine|October 26, 2024
Poor prognostic factors independently impact remission and treatment escalation in rheumatoid arthritis regardless of disease activity: A nationwide prospective cohort studyYou-Jung Ha, Seunghwan Shin, Se Rim Choi, et al.
BMC Cancer|January 30, 2024
Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysisSangwon Shin, Jimin Moon, Chiyoon Oum, et al.
Rheumatology (Oxford, England)|March 21, 2019
Association between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional surveyAnna Shin, Seunghwan Shin, Ji Hyoun Kim, et al.
Psychiatry Research|November 13, 2016
Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophreniaSeunghwan Shin, Chan-Woo Yeom, Cheolmin Shin, et al.
Cancers|August 27, 2021
Deep Learning Analysis of CT Images Reveals High-Grade Pathological Features to Predict Survival in Lung AdenocarcinomaYeonu Choi, Jaehong Aum, Se-Hoon Lee, et al.
Frontiers in Immunology|December 13, 2021
Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe DiseaseJi Yeon Lee, Jee Young Lee, Jae-Hoon Ko, et al.
Leukemia Research|March 9, 2012
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular responseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Scientific Reports|February 16, 2023
Author Correction: Extracellular pyruvate kinase M2 promotes osteoclastogenesis and is associated with radiographic progression in early rheumatoid arthritisDong Woo Han, Yong Seok Choi, Hye Won Kim, et al.
Scientific Reports|March 8, 2022
Extracellular pyruvate kinase M2 promotes osteoclastogenesis and is associated with radiographic progression in early rheumatoid arthritisDong Woo Han, Yong Seok Choi, Hye Won Kim, et al.
NPJ Breast Cancer|August 30, 2023
Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancerSangjoon Choi, Soo Ick Cho, Wonkyung Jung, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Joint Bone Spine|October 26, 2024
Poor prognostic factors independently impact remission and treatment escalation in rheumatoid arthritis regardless of disease activity: A nationwide prospective cohort studyYou-Jung Ha, Seunghwan Shin, Se Rim Choi, et al.
BMC Cancer|January 30, 2024
Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysisSangwon Shin, Jimin Moon, Chiyoon Oum, et al.
Rheumatology (Oxford, England)|March 21, 2019
Association between socioeconomic status and comorbidities among patients with rheumatoid arthritis: results of a nationwide cross-sectional surveyAnna Shin, Seunghwan Shin, Ji Hyoun Kim, et al.
Psychiatry Research|November 13, 2016
Activity monitoring using a mHealth device and correlations with psychopathology in patients with chronic schizophreniaSeunghwan Shin, Chan-Woo Yeom, Cheolmin Shin, et al.
Cancers|August 27, 2021
Deep Learning Analysis of CT Images Reveals High-Grade Pathological Features to Predict Survival in Lung AdenocarcinomaYeonu Choi, Jaehong Aum, Se-Hoon Lee, et al.
Frontiers in Immunology|December 13, 2021
Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe DiseaseJi Yeon Lee, Jee Young Lee, Jae-Hoon Ko, et al.
Leukemia Research|March 9, 2012
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular responseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Scientific Reports|February 16, 2023
Author Correction: Extracellular pyruvate kinase M2 promotes osteoclastogenesis and is associated with radiographic progression in early rheumatoid arthritisDong Woo Han, Yong Seok Choi, Hye Won Kim, et al.
Scientific Reports|March 8, 2022
Extracellular pyruvate kinase M2 promotes osteoclastogenesis and is associated with radiographic progression in early rheumatoid arthritisDong Woo Han, Yong Seok Choi, Hye Won Kim, et al.
NPJ Breast Cancer|August 30, 2023
Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancerSangjoon Choi, Soo Ick Cho, Wonkyung Jung, et al.
Pageof 3